COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 8th, 2019 • Moderna, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionThis Fifth Amendment to Collaboration and License Agreement (this “Fifth Amendment”) dated as of May 3, 2019 (the “Fifth Amendment Effective Date”), is made by and between ModernaTX, Inc. (f/k/a Moderna Therapeutics, Inc.), a corporation organized and existing under the laws of Delaware (“Moderna”), and Merck Sharp & Dohme Corp., a corporation organized and existing under the laws of New Jersey (“Merck”). Each of Moderna and Merck may be referred to herein as a “Party” or together as the “Parties”.